trial

Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug Dependence

NCTId NCT01037075
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 82 (actual)
Sponsored by National Institute on Drug Abuse (NIDA)
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
82 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2006-05-14
Primary completion
—
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
—

Sponsors

National Institute on Drug Abuse (NIDA)Lead Sponsor
University of Maryland, Baltimore CountyCollaborator

Investigators

1
Carol A. Tamminga, M.D.Principal Investigator

Sites

2 total
Baltimore, United StatesRockville, United States

Facts & assertions

3 sourced
Enrollment
82
Phase
NA
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
National Institute on Drug Abuse (NIDA)
company
collaborator
University of Maryland, Baltimore County
company
indication
Substance-Related Disorders
indication
Drug Abuse/Dependency
indication
Schizophrenia
indication
investigator
Carol A. Tamminga, M.D.
person